Source: Brisbane MedTech start-ups wow global investors to win top gongs in San Francisco

Two Brisbane MedTech companies have secured top prizes at a shark-tank style pitch challenge in San Francisco, attracting global investor attention in the process.

Field Orthopaedics based in Teneriffe, and Max Kelsen based in Spring Hill, took out gold and bronze in the Innovator’s Pitch Challenge at the Redefining Early Stage Investment Conference (RESI), powered by Life Science Nation. Both are members of Brisbane Economic Development Agency’s (BEDA) MedTech Accelerator cohort.

The challenge provided significant exposure to early-stage ventures seeking strategic partnerships as part of the JP Morgan Health Week, attracting more than 500 global investors.

Field Orthopaedics secured the top prize for innovative surgical screws and nails for treating complex fractures.

Max Kelsen claimed bronze with its machine learning solutions to transform the way scientists store, analyse and work with data to fast-track vital research.

A third company – Microbio – also received a special mention prize for their rapid test for sepsis.

“Getting recognised as a leading innovation hub is important for the future of our local economy because it will attract more businesses, create more jobs and help Brisbane get even better”, said Lord Mayor Adrian Schrinner.

It is hoped these connections result in fresh investment, to help bring these amazing products onto the market sooner, while supporting jobs and better resources to grow this vital industry in Brisbane.

Field Orthopaedics CEO Patryk Kania said support offered through BEDA’s MedTech Accelerator would help the company take the next steps in its commercialisation journey.

Max Kelson’s Digital Health Lead and Product Manager for PROPeL, Navid Toosi Saidy said the company was now well positioned to expand its presence in the US and unlock access to global markets.

A range of Brisbane MedTech companies – Clinials, De Motu Cordis, Laronix, Microbio and Midnight Health found recognition and interest from global investors in addition to being awarded finalist seats.

BEDA’s MedTech Accelerator supports the growth of local industry by empowering business leaders to globally scale and acquire funding through strategic pathways.

The cohort will continue to engage with strategic partners and investors. Also worth noting is that eevi and TickerCardiology will join the RESI BIO conference in Boston later in 2023.

Program facilitator, US-based Life Science Nation CEO Dennis Ford said Brisbane was growing its global reputation as a modern city supporting key growth industries like MedTech.

Leave a Reply

Your email address will not be published. Required fields are marked *